CHARACTERISTICS OF OUTPATIENTS INITIATED ON OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA IN JAPAN

被引：0
|
作者：
Ye, W. [1 ]
Nakahara, N. [1 ]
Takahashi, M. [1 ]
Ascher-Svanum, H. [2 ]
机构：
[1] Eli Lilly Japan KK, Kobe, Hyogo, Japan
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)73322-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A554 / A554
页数：1
相关论文
共 50 条
  • [41] Effects of olanzapine and risperidone treatment on major hormones in patients with schizophrenia
    Yazici, A
    Taneli, B
    Yazici, K
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S232 - S232
  • [42] A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia
    Alvarez, Enrique
    Ciudad, Antonio
    Olivares, Jose Manuel
    Bousono, Manuel
    Gomez, Juan Carlos
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (03) : 238 - 249
  • [43] Olanzapine versus risperidone - A prospective comparison of clinical and economic outcomes in schizophrenia
    Edgell, ET
    Andersen, SW
    Johnstone, BM
    Dulisse, B
    Revicki, D
    Breier, A
    [J]. PHARMACOECONOMICS, 2000, 18 (06) : 567 - 579
  • [44] Cost and effectiveness of switching from risperidone to olanzapine in the treatment of schizophrenia
    Thomas, NA
    Faries, D
    Ascher-Svanum, H
    Nyhuis, AW
    Kinon, BJ
    [J]. VALUE IN HEALTH, 2006, 9 (03) : A67 - A67
  • [45] Risperidone treatment of outpatients with schizophrenia: No evidence of sex differences in treatment response
    Labelle, A
    Light, M
    Dunbar, F
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2001, 46 (06): : 534 - 541
  • [46] Risperidone for the treatment of outpatients with schizophrenia: No evidence of gender differences in treatment response
    Labelle, A
    Light, MJ
    [J]. SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 235 - 236
  • [47] Patient characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophrenia
    Ren, XHS
    Kazis, LE
    Lee, AF
    Huang, YH
    Hamed, A
    Cunningham, F
    Herz, L
    Miller, DR
    [J]. SCHIZOPHRENIA RESEARCH, 2005, 77 (2-3) : 167 - 177
  • [48] Comparison of quetiapine, olanzapine, and risperidone in schizophrenia
    Sacchetti, E
    Valsecchi, P
    Regini, C
    Galluzzo, A
    Cacciani, P
    Agrimi, E
    Mencacci, C
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S286 - S286
  • [49] An open-label randomized comparison of olanzapine versus risperidone in the treatment of childhood-onset schizophrenia
    Mozes, Tamar
    Ebert, Tanya
    Michal, Sabbagh-Etun
    Spivak, Baruch
    Weizman, Abraham
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (04) : 393 - 403
  • [50] Hyperprolactinemia during schizophrenia treatment with atypical antipsychotics: oral risperidone, depot risperidone, and oral olanzapine
    Loza, B
    Bartyzel, M
    Matysiewicz, W
    Mazurek, I
    Mosiolek, A
    Opielak, G
    Varghese, S
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S522 - S522
12345